未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Ethanol precipitation process affects the pharmacokinetic characteristics of major active glycosides of Qiong-Yu-Gao: evidences in normal and cisplatin-induced acute kidney injury rats乙醇沉淀工艺影响琼玉膏主要活性苷类的药代动力学特征:正常和顺铂诱导的急性肾损伤大鼠的证据
Chen, Lin-Xia; Wang, Yao; Zhu, Run-Wen; Zhou, Jing; Shen, Ji-Chen; Wu, Cheng-Ying; Shen, Hong; Qin, Xiang-Ling; Long, Fang; Li, Song-Lin
分享
收藏QKI-induced circ_0001766 inhibits colorectal cancer progression and rapamycin resistance by miR-1203/PPP1R3C/mTOR/Myc axisQKI诱导的circ_0001766通过miR-1203/PPP1R3C/mTOR/Myc轴抑制结直肠癌进展和雷帕霉素耐药性。
Zhou, Yulai; Gao, Yan; Peng, Yinghui; Cai, Changjing; Han, Ying; Chen, Yihong; Deng, Gongping; Ouyang, Yanhong; Shen, Hong; Zeng, Shan; Du, Yangfeng; Xiao, Zemin
分享
收藏
分享
收藏
分享
收藏
分享
收藏Clinicopathological spectrum, management, and outcome of ectopic parathyroid carcinoma: Experience with 24 cases
Zhao, Teng; Huang, Jian; Wang, Yuting; Zhang, Dongxue; Zhang, Teng; Lu, Ruigang; Gu, Hua; Jin, Mulan; Shen, Hong; Liu, Xing; Feng, Dalin; Wang, Jiacheng; Wang, Qian; Wei, Bojun
分享
收藏Comprehensive molecular classification predicted microenvironment profiles and therapy response for hepatocellular carcinoma
Chen, Yihong; Deng, Xiangying; Li, Yin; Han, Ying; Peng, Yinghui; Wu, Wantao; Wang, Xinwen; Ma, Jiayao; Hu, Erya; Zhou, Xin; Shen, Edward; Zeng, Shan; Cai, Changjing; Qin, Yiming; Shen, Hong
分享
收藏
分享
收藏Interim survival analysis of the randomized phase III GEMSTONE-302 trial: sugemalimab or placebo plus chemotherapy as first-line treatment for metastatic NSCLC (vol 4, pg 860, 2023)
Zhou, Caicun; Wang, Ziping; Sun, Meili; Cao, Lejie; Ma, Zhiyong; Wu, Rong; Yu, Yan; Yao, Wenxiu; Sun, Si; Chen, Jianhua; Zhuang, Wu; Cui, Jiuwei; Chen, Xueqin; Lu, You; Shen, Hong; Hu, Chunhong; Liu, Jiwei; Liu, Yunpeng; Wang, Mengzhao; Li, Xingya; Sun, Ping; Shu, Yongqian; Zhou, Jianying; Li, Jingzhang; Gu, Kangsheng; Wang, Changli; Zhao, Hui; Zhang, Yiping; Liu, Chunling; Wang, Jingru; Chen, Rumei; Qin, Mengmeng; Wang, Hao; Yang, Jason
分享
收藏
分享
收藏Interim survival analysis of the randomized phase III GEMSTONE-302 trial: sugemalimab or placebo plus chemotherapy as first-line treatment for metastatic NSCLC
Zhou, Caicun; Wang, Ziping; Sun, Meili; Cao, Lejie; Ma, Zhiyong; Wu, Rong; Yu, Yan; Yao, Wenxiu; Sun, Si; Chen, Jianhua; Zhuang, Wu; Cui, Jiuwei; Chen, Xueqin; Lu, You; Shen, Hong; Hu, Chunhong; Liu, Jiwei; Liu, Yunpeng; Wang, Mengzhao; Li, Xingya; Sun, Ping; Shu, Yongqian; Zhou, Jianying; Li, Jingzhang; Gu, Kangsheng; Wang, Changli; Zhao, Hui; Zhang, Yiping; Liu, Chunling; Wang, Jingru; Chen, Rumei; Qin, Mengmeng; Wang, Hao; Yang, Jason
分享
收藏A multi-omics analysis reveals CLSPN is associated with prognosis, immune microenvironment and drug resistance in cancers
Chen, Yihong; Wen, Haicheng; Li, Yin; Han, Ying; Tan, Jun; Guo, Cao; Cai, Changjing; Liu, Ping; Peng, Yinghui; Liu, Yihan; Wang, Xinwen; Zeng, Shan; Feng, Ziyang; Shen, Hong
分享
收藏
分享
收藏
分享
收藏